 BEIJING, Aug. 23, 2021 PRNewswire -- Concord Medical Services Holdings Limited Concord Medical or the Company NYSE: CCM, a healthcare provider specializes in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced an investment of RMB400.0 million US62.2 million in Concord Medicals subsidiary, Meizhong Jiahe Medical Science Technology Development Group Co., Ltd. Meizhong Jiahe from several investors led by WisdoMont Asset Management Shanghai Co., Ltd. 